{"id":"https://openalex.org/W2015949637","doi":"https://doi.org/10.1158/1538-7445.am2012-lb-225","title":"Abstract LB-225: Phase 2 Trial of nab-paclitaxel plus carboplatin for advanced NSCLC in patients at risk of bleeding from VEGF directed therapies","display_name":"Abstract LB-225: Phase 2 Trial of nab-paclitaxel plus carboplatin for advanced NSCLC in patients at risk of bleeding from VEGF directed therapies","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2015949637","doi":"https://doi.org/10.1158/1538-7445.am2012-lb-225","mag":"2015949637"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-lb-225","doi":"https://doi.org/10.1158/1538-7445.am2012-lb-225","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-lb-225","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090253314","display_name":"Erin Marie Bertino","orcid":"https://orcid.org/0000-0003-3174-0928","observed_orcids":["https://orcid.org/0000-0003-3174-0928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erin M. Bertino","raw_affiliation_strings":["1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015548619","display_name":"Miguel Angel Villalona-Calero","orcid":"https://orcid.org/0000-0002-1991-5070","observed_orcids":["https://orcid.org/0000-0002-1991-5070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miguel A. Villalona-Calero","raw_affiliation_strings":["1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090821383","display_name":"Patrick S. Nana-Sinkam","orcid":"https://orcid.org/0009-0001-7635-6893","observed_orcids":["https://orcid.org/0009-0001-7635-6893"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Nana-Sinkam","raw_affiliation_strings":["1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054950412","display_name":"Sarah Cantrel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Cantrel","raw_affiliation_strings":["1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047689037","display_name":"Meliha Rahmani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meliha Rahmani","raw_affiliation_strings":["1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072676975","display_name":"Carrie Symmes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carrie Symmes","raw_affiliation_strings":["1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104071006","display_name":"Gary S. Phillips","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary S. Phillips","raw_affiliation_strings":["1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004712121","display_name":"Gregory A. Otterson","orcid":"https://orcid.org/0000-0001-9877-8512","observed_orcids":["https://orcid.org/0000-0001-9877-8512"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory A. Otterson","raw_affiliation_strings":["1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Ohio State Univ. Comp. Cancer Ctr., Columbus, OH","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"LB","last_page":"225"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6942999958992004,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6942999958992004,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.2915000021457672,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9620000123977661},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.9380000233650208},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hemoptysis","display_name":"hemoptysis","score":0.8550000190734863},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.878000020980835},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.7720000147819519},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.4779999852180481},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8579999804496765},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8370000123977661},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.753000020980835},{"id":"https://openalex.org/keywords/neuropathy","display_name":"neuropathy","score":0.699999988079071},{"id":"https://openalex.org/keywords/microrna-expression","display_name":"microRNA expression","score":0.45500001311302185},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6650000214576721},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.30799999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9004983901977539},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.870252251625061},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6808454990386963},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5674231052398682},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5456687211990356},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5310758948326111},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.44799676537513733},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4421234130859375},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.439770370721817},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.20545059442520142},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-lb-225","doi":"https://doi.org/10.1158/1538-7445.am2012-lb-225","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-lb-225","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1991828019","https://openalex.org/W2521646602","https://openalex.org/W1865662271","https://openalex.org/W2991485684","https://openalex.org/W2596957725","https://openalex.org/W2568863723","https://openalex.org/W2280283394","https://openalex.org/W4367046623","https://openalex.org/W2586304181","https://openalex.org/W1979483767"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"The":[2,206,325],"addition":[3],"of":[4,54,67,102,150,254,327,355,382,387],"bevacizumab":[5],"(Bev)":[6],"to":[7,46,110,123,175,179,283,304],"platinum":[8],"based":[9],"chemotherapy":[10],"results":[11],"in":[12,24,36,78,92,136,250,299,337,346,370],"higher":[13,57,75],"response":[14,76],"rate":[15,77],"(RR),":[16],"progression-free":[17],"survival":[18,22,130,359],"(PFS),":[19],"and":[20,60,104,129,141,225,241,271,279,312,329,358,362,366],"overall":[21],"(OS)":[23],"advanced":[25],"non-small":[26],"cell":[27,212,349],"lung":[28],"cancer":[29],"(NSCLC).":[30],"However,":[31],"Bev":[32,98,342],"is":[33,50,320,351,364],"not":[34,321],"indicated":[35],"patients":[37,79,137],"(pts)":[38],"with":[39,43,56,80,94,139,189,306,334],"squamous":[40,81,147,211,348],"histology":[41,82,209],"or":[42],"hemoptysis":[44,235],"due":[45,178,282],"bleeding":[47],"risk.":[48],"Nab-paclitaxel":[49],"a":[51,74,116],"novel":[52],"formulation":[53],"paclitaxel":[55],"dose":[58],"tolerance":[59],"potentially":[61],"improved":[62],"efficacy.":[63],"A":[64],"previous":[65],"study":[66,288,345],"nab-paclitaxel/Carboplatin":[68],"(using":[69],"an":[70,200],"alternative":[71,111],"schedule)":[72],"showed":[73],"(Socinski,":[83],"et":[84],"al,":[85],"ASCO":[86],"2010,":[87],"LBA7511).":[88],"We":[89,114],"hypothesized":[90],"that":[91],"pts":[93,145,184,255,302,339],"NSCLC":[95,221,338],"ineligible":[96,340],"for":[97,153,341,391],"therapy":[99],"the":[100,300,347,371,383,388],"combination":[101,326],"nab-paclitaxel":[103,140,330],"carboplatin":[105,142],"(Cb)":[106],"would":[107],"be":[108,368],"superior":[109],"doublets.":[112],"Methods:":[113],"conducted":[115],"single-arm,":[117],"single-institution":[118],"phase":[119],"2":[120],"trial":[121],"(NCT00729612)":[122],"evaluate":[124],"RR":[125],"(primary":[126],"endpoint),":[127],"safety/toxicity,":[128],"(OS,":[131],"PFS":[132],"-":[133],"secondary":[134],"endpoints)":[135],"treated":[138],"(Cb).":[143],"Eligible":[144],"included:":[146],"histology,":[148],"history":[149],"hemoptysis,":[151],"requirement":[152],"anticoagulation.":[154],"Correlative":[155,353],"studies":[156,354],"included":[157,234,256],"blood":[158],"microRNA":[159,356],"profiles":[160,357],"pre-treatment.":[161],"Treatment":[162],"was":[163,210,294],"administered":[164],"every":[165],"21":[166],"days,":[167],"initially":[168],"at":[169],"300":[170],"mg/m2/AUC=6,":[171],"but":[172],"then":[173],"adjusted":[174],"260":[176],"mg/m2/AUC6":[177],"excess":[180],"neuropathy.":[181],"Results:":[182],"63":[183,192],"(21":[185,308],"female,":[186],"42":[187],"male)":[188],"median":[190],"age":[191],"yrs":[193],"(range":[194],"36-82)":[195],"were":[196],"enrolled.":[197],"Pts":[198],"had":[199],"average":[201],"50":[202],"pk-yrs":[203],"tobacco":[204],"use.":[205],"most":[207],"common":[208],"carcinoma":[213],"(48":[214],"pts/76%),":[215],"followed":[216],"by":[217],"adenocarcinoma":[218],"(9":[219],"pts/14%),":[220],"NOS":[222],"(4":[223],"pts/6%)":[224],"adenosquamous":[226],"(2":[227,239],"pts/3%).":[228],"In":[229],"non-squamous":[230],"pts,":[231],"eligibility":[232],"criteria":[233],"(11":[236],"pts),":[237,240],"thrombosis":[238],"therapeutic":[242],"anticoagulation":[243],"(1":[244],"pt).":[245],"Grade":[246],"3-4":[247],"toxicities":[248],"seen":[249],"more":[251],"than":[252],"10%":[253],"hematologic":[257],"toxicity":[258,336],"(36":[259],"pts/57%),":[260],"febrile":[261],"neutropenia":[262],"(9/14%),":[263],"infection":[264],"(15/24%),":[265],"sensory":[266],"neuropathy":[267],"(17/27%),":[268],"dyspnea":[269],"(10/16%)":[270],"dehydration":[272],"(8/13%).":[273],"Four":[274],"deaths_including":[275],"1":[276,280],"sudden":[277],"death":[278,281],"respiratory":[284],"failure_were":[285],"reported":[286],"on":[287],"as":[289],"grade":[290],"5":[291],"toxicity.":[292],"ORR":[293],"41%":[295],"(22":[296],"PR/0":[297],"CR)":[298],"53":[301],"evaluable":[303],"date":[305],"39%":[307],"pts)":[309,315],"stable":[310],"disease":[311],"19%":[313],"(10":[314],"progressive":[316],"disease.":[317],"PFS/OS":[318],"data":[319,360],"yet":[322],"available.":[323],"Conclusions:":[324],"Cb":[328],"demonstrates":[331],"promising":[332],"efficacy":[333],"tolerable":[335],"therapy.":[343],"Further":[344],"population":[350],"warranted.":[352],"(OS":[361],"PFS)":[363],"maturing":[365],"will":[367],"available":[369],"near":[372],"future.":[373],"Citation":[374],"Format:":[375],"{Authors}.":[376],"{Abstract":[377],"title}":[378],"[abstract].":[379],"In:":[380],"Proceedings":[381],"103rd":[384],"Annual":[385],"Meeting":[386],"American":[389],"Association":[390],"Cancer":[392,403],"Research;":[393],"2012":[394],"Mar":[395],"31-Apr":[396],"4;":[397],"Chicago,":[398],"IL.":[399],"Philadelphia":[400],"(PA):":[401],"AACR;":[402],"Res":[404],"2012;72(8":[405],"Suppl):Abstract":[406],"nr":[407],"LB-225.":[408],"doi:1538-7445.AM2012-LB-225":[409]},"counts_by_year":[{"year":2014,"cited_by_count":3}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}